Medico Remedies News

Medico Remedies Q3 FY26 Results: Revenue Up 48.6%

Medico Remedies Limited reported strong Q3 FY26 performance with revenue rising 48.6% YoY to ₹5,868.29 lakhs and net profit growing 9.6% to ₹287.23 lakhs for quarter ended December 31, 2025.

Medico Remedies Secures ₹37.17 Cr UP Govt Order

Medico Remedies Limited secured a government supply order worth ₹37.17 crores from Uttar Pradesh Medical Supplies Corporation Limited for multiple drug supplies to be completed by October 2026.

Medico Remedies Secures ₹73 Crore Order

Medico Remedies has secured a significant order worth ₹73 crore, representing a substantial business development for the pharmaceutical company with a current market capitalisation of ₹390 crore.

Medico Remedies Reports Strong Q2 Performance with Revenue Growth and Improved Profitability

Medico Remedies Limited reported quarterly revenue of Rs 526.35 lakh and net profit of Rs 356.82 lakh for the quarter ended September 30, 2025, with half-year revenue reaching Rs 932.69 lakh and net profit of Rs 438.63 lakh. The pharmaceutical formulations manufacturer showed significant growth with international sales contributing Rs 467.54 lakh compared to domestic sales of Rs 54.29 lakh in the latest quarter.

Medicore Remedies Receives GMP Compliance Certificate from Ukraine's State Service on Medicines and Drugs Control

Medicore Remedies' Palghar manufacturing facility received GMP compliance certification from Ukraine's State Service on Medicines and Drugs Control on 10 November, 2025, following a successful inspection. The PIC/S certification will enhance the facility's global credibility and facilitate access to regulated markets including Thailand, Singapore, Malaysia, Jordan, and Iraq.